Search Results - recombinant human igg1 f

Omalizumab Biosimilar C020P.NA Syd Labs

Omalizumab Biosimilar, N297A Mutant | C020P.NA

Omalizumab Biosimilar, N297A Mutant. Omalizumab biosimilar CHO stable cell line is available for licensing to manufacture the omalizumab protein. The research grade omalizumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype...

Palivizumab Biosimilar C021P.NA Syd Labs

Palivizumab Biosimilar, N297A Mutant | C021P.NA

Palivizumab Biosimilar, N297A Mutant. Palivizumab biosimilar CHO stable cell line is available for licensing to manufacture the palivizumab biosimilar protein. The research grade palivizumab biosimilar protein is for research use only (RUO). Recombinant human IgG1...

Palivizumab Biosimilar C021P.05 Syd Labs

Palivizumab Biosimilar, Endotoxin 0.05 EU/mg | C021P.05

Palivizumab Biosimilar, Endotoxin 0.05 EU/mg. Palivizumab biosimilar CHO stable cell line is available for licensing to manufacture the palivizumab biosimilar protein. The research grade palivizumab biosimilar protein is for research use only (RUO). Recombinant human...

Infliximab Biosimilar C011P.NA Syd Labs

Infliximab Biosimilar, N297A Mutant | C011P.NA

Infliximab Biosimilar, N297A Mutant. Infliximab biosimilar CHO stable cell line is available for licensing to manufacture the Infliximab biosimilar protein. The research grade infliximab biosimilar protein is for research use only (RUO). Recombinant human IgG1...